The pharmacology and clinical properties of Kalopanax pictus

Journal of Medicinal Plants Research

Volumn 3, Issue 9, 2009, Pages 613-620

  Hyun, Tae Kyung ^a   Kim, Ju Sung ^b  

^a Institut fuer Pflanzenwissenschaften   (Austria)

^b Kangwon National University   (South Korea)

Author keywords

Anti diabetic; Anti inflammatory; Anti rheumatoidal activity; Araliaceae; Hepatoprotective effect; Kalopanax pictus; Kalopanaxsaponins A

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; CONIFERIN; CONIFERYL ALCOHOL; ERYTHRAKINE; FERULYALDEHYDE; GLYCOSIDE; KALOPANAX PICTUS EXTRACT; KALOPANAXSAPONIN A; KALOPANAXSAPONIN B; KALOPANAXSAPONIN C; KALOPANAXSAPONIN D; KALOPANAXSAPONIN E; KALOPANAXSAPONIN F; KALOPANAXSAPONIN G; KALOPANAXSAPONIN H; KALOPANAXSAPONIN I; KALOPANAXSAPONIN J; KALOPANAXSAPONIN K; LIGNAN DERIVATIVE; LIRIODENDRIN; LIVER PROTECTIVE AGENT; PHENOL DERIVATIVE; PLANT EXTRACT; SAPINDOSIDE C; SEPTEMLOSIDE III; SYRINGIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CHEMICAL COMPOSITION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; EXPERIMENTAL STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KALOPANAX; KALOPANAX PICTUS; LIVER INJURY; MEDICINAL PLANT; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAIN; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; STRESS;

ARALIACEAE; KALOPANAX; KALOPANAX PICTUS;

EID: 73449131150     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Abesundara KJM, Matsui T, Matsumoto K (2004). α-Glycosidase inhibitory activity of some Sri Lanka plant extracts, one of which, Cassia auriculata, exerts a strong antihyperglycemic effect in rats comparable to the therapeutic drug acarbose. J. Agric. Food Chem. 52: 2541-2545.
2. American Diabetes Association (2005). Diagnosis and classification of diabetes mellitus. Diabetes Care 28: 37-42.
3. Aniya Y, Koyama T, Miyagi C, Miyahira M, Inomata C, Kinoshita S, Ichiba T (2005). Free radical scavenging and hepatoprotective actions of the medicinal herb, Crassocephalum crepidioides from the Okinawa islands. Bio. Pharm. Bull. 28: 19-23.
4. Babich H, Sedletcaia A, Kenigsberg B (2002). In vitro cytotoxicity of protocatechuic acid to cultured human cells from oral tissue: involvement in oxidative stress. Pharmacol. Toxicol. 91: 245-253.
5. Bailey CJ, Turner RC (1996). Metformin. N. Engl. J. Med. 334: 574-579.
6. Billinghasm ME (1983). Models of arthritis and the search for anti arthritic drugs. Pharmacol. Ther. 21: 389-428.
7. Byun JH, Shin MK (1986). Comparison of the effects of cortex kalopanaxii and cortex erythrinae on the analgesia, anti-inflammation, muscle-relaxation. Korean Oriental Med. Soc. 7: 136-142.
8. Calixto JB, Campos MM, Otuki MF, Santos ARS (2004). Antiinflammatory compounds of plant origin. Part II. Modulation of proinflammatory cytokine, chemokines and adhesion molecules. Planta Med. 70: 93-103.
9. Cassim B, Mody G, Bhoola K (2002). Kallikrein cascades and cytokines in inflamed joints. Pharmacol. Ther. 94: 1-34.
10. Cederbaum AI (1989). Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radic. Biol. Med. 7: 537-539.
11. Charles A, Dinarello MD (2000). Proinflammatory cytokines. CHEST 118: 503-508
12. th Ann. Conv. Pharmaceut. Soc. Korea and Int.ernational Sym. 236.
13. Choi J, Han YN, Lee KT, Park KY, Kwak TS, Kwon SH, Park HJ (2001a). Anti-lipid peroxidative principles from the stem bark of of Kalopanax pictus Nakai. Arch. Pharm. Res. 24: 536-540.
14. Choi J, Huh K, Kim S-H, Lee K-T, Kwon S-H, Park H-J (2001b). Toxicology of Kalopanax pictus extract and hematological effect of the isolated anti-rheumatoidal kalopanaxsaponin A on the Freunds complete adjuvant reagent-treated rat. Arch. Pharm. Res. 24: 119-125.
15. Choi J, Huh K, Kim S-H, Lee K-T, Lee H-K, Park H-J (2002a). Kalopanaxsaponin A from Kalopanax pictus, a potent antioxidant in the rheumatoidal rat treated with Freund' complete adjuvant reagent. J. Ethnopharmacol. 79: 113-118.
16. Choi J, Huh K, Lim S-H, Lee K-T, Park H-J, Han YN (2002b). Antinociceptive and anti-rheumatoidal effects of Kalopanax pictus extract and its saponin components in experimental animals. J. Ethnopharmacol. 79: 199-204.
17. th Ann. Conv. Pharmaceut. Soc. Korea and Int.ernational Sym. p. 188.
18. Chung DH (1974). Korean Flora. Vol 1. Academy Press, Seoul., pp. 414-415.
19. Ekstrand-Hammarstroem B, Österlund C, Lilliehöök B, Bucht A (2006). Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kB and inflammatory responses in lung epithelial cells. Clin. Exp. Immunol. 147: 359-369.
20. Grover JK, Yadav S, Vats V (2002). Medicinal plants of India with antidiabetic potential. J. Ethnopharmacol. 81: 81-100.
21. Guan S, Ge D, Liu T, Ma XH, Cui ZF (2009). Protocatechuic acid promotes cell proliferation and reduces basal apoptosis in cultured neural stem cells. Toxicol. In vitro 23: 201-208.
22. Han J, Richter B, Li Z, Kravchenko V, Ulevitch RJ (1995). Molecular cloning of the p. 38 MAP kinase. Biochem. Biophys. Acta. 16: 224-227.
23. Hwang Y-S, Park K-K, Park H-J, Chung W-Y (2008). Kalopanaxsaponin A inhibits the invasion of MDA-MB-231 human metastatic breast cancer cells. Cancer Prev. Res. 13: 108-115.
24. Jang HI, Yang SB, Choi CW, Park MH, Hong SK, Kim HY (2005). Antiinflammation composition including Kanapanax cortex and ginger extract. KR Patent No. KR/10/2005/0017080.
25. Jiangsu Medical College (1977). The dictionary of chinese crude drugs. Shanghai Scientific Technologic Publisher, Shanghai., p.p. 1277.
26. Johnston KL, Clifford MN, Morgan LM (2003). Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am. J. Clin. Nutr. 78: 728-733.
27. Kalopanax pictus Nakai. Arch. Pharm. Res. 24: 536-540.
28. Khorlin AY, Vcn'yaminova AG, Kochetov NK (1966). Triterpenoid saponins. Communication 18, Structure of kalopanax saponin B. Russ. Chem. Bull. Int. Ed. 15: 1588-1594.
29. Kim DH (2007). The method for bean curd from Kalopanax sap. KR Patent No. KR/10/2007/0066001.
30. Kim D-H, Bae E-A, Han MJ, Park H-J, Choi J-W (2002a). Metabolism of kalopanaxsaponin K by human intestinal bacteria and antirheumatoid arthritis activity of their metabolites. Bio. Pharm. Bull. 25: 68-71.
31. Kim D-H, Yu K-W, Bae E-A, Park H-J, Choi J-W (1998a). Metabolism of kalopanaxsaponin B and H by human intestinal bacteria and antidiabetic activity of their metabolites. Bio. Pharm. Bull. 21: 360-365.
32. Kim D-W, Bang K-H, Rhee Y-H, Lee K-T, Park H-J (1998b). Growth inhibitory activities of Kalopanaxsaponins A and I against human pathogenic fungi. Arch. Pharm. Res. 21: 688-691.
33. Kim IG, Jeon YW, Kim BH, Hong JI, Lee SY (2006). Manufacturing method of alcoholic beverages having deodorizing function with Kalopanax, Hovenia dulcis Thunb. KR Patent No. KR/10/2006/0084189.
34. Kim IT, Park Y-M, Shin K-M, Ha J, Choi J, Jung H-J, Park H-J, Lee K-T (2004). Anti-inflammatory and anti-nociceptive effects of the extract from Kalopanax pictus, Pueraria thunbergiana and Rhus verniciflua. J. Ethnopharmacol. 94: 165-173.
35. Kim MJ, Kim JS, Kang WH, Yeon KD (2002b). Antimutagenic and cytotoxic effect of extracts of Kalopanax pictus Nakai Endodermis.
36. Kim TJ (1996). Korean resources plants. Seoul National University Press, Seoul, p.p. 169.
37. Kim YK, Kim RG, Park SJ, Ha JH, Choi JW, Park HJ, Lee KT (2002c). In vitro anti-inflammatory activity of kalopanaxsaponin A isolated from Kalopanax pictus in murine macrophage RAW 264.7 cells. Biol.
38. Kim YW, Lee H (2007). Effect of herbal-acupuncture with Erythrinae Cortex solution at the Joksamni (ST36) of mice with collagen-induced arthritis. J. Korean Acupuncture and Moxibustion Soc. 24: 171-183.
39. Kirpichnikov D, McFarlane SI, Sowers JR (2002). Metformin: an update. Ann. Intern. Med. 137: 25-33.
40. Ko BS, Kim HK, Park S (2002). Insulin sensitizing and insulin-like effects of water extracts from Kalopanax pictus Nakai in 3T3-L1. J. Korean Soc. Agric. Chem. Biotechnol. 45: 42-46.
41. Kondo Y, Takano F, Yoshida K, Hojo H (1994). Protection by sinomenine against endodoxin-induced fulminant hepatitis in galactosamine-sensitized mice. Biochem. Pharmacol. 48: 1050-1052.
42. Korean J. Medicinal. Crop Sci. 10: 132-138.
43. Lee E, Choi MY, Park HJ, Cha BC, Cho SH (1995). Chemical constituents and biological activity of Kalopanacis Cortex. Kor. J. Pharmacogn. 26: 122-129.
44. Lee EB, Li DW (2003). Composition containing an ethyl acetate soluble extract from Kalopanax pictus Nakai and kalopanaxsaponin A derivatives isolated therein for protecting and treating inflammatory and rheumatic disease. WO Patent No. WO/2003/099305.
45. Lee EB, Li DW, Hyun JE, Kim IH, Whang WK (2001). Anti-inflammatory activity of methanol extract of Kalopanax pictus bark and its fractions. J. Ethnopharmacol. 77: 197-201.
46. Lee JC, Laydon JT, McDonnel PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR (1994). A protein kinase involved in the regulation of inflammatiory cytokine biosynthesis. Nature. 372: 739-746.
47. Lee M, Hahn DR (1991). Triterpenoidal saponins from the leaves of Kalopanax pictum var. chinense. Arch. Pharm. Res. 14: 124-128.
48. Li DW, Hyun JE, Jeong CS, Kim YS, Lee EB (2003). Antiinflammatory activity of α -hederin methyl ester from the alkaline hydrolysate of the butanol fraction of Kalopanax pictus bark extract. Biol. Pharm. Bull. 26: 429-433.
49. Li DW, Lee EB, Kang SS, Hyun JE, Whang WK (2002). Activity-guided isolation of saponins from Kalopanax pictus with anti-inflammatory activity. Chem. Pharm. Bull. 50: 900-903.
50. Lindy S, Turto H, Uitto J, Vainio K (1971). Origin of synovial fluid lactate dehydrogenase in rheumatoid arthritis. Clin. Chim. Acta 35: 377-382.
51. Meldrum KK, Meldrum DR, Hile KL, Yerkes EB, Ayala A, Cain MP, Rink RC, Casale AJ, Kaefer MA (2001). p38 MAPK mediates renal tubular cell TNF-α production and TNF-α-dependent apoptosis during simulated ischemia. Am. J. Physiol. Cell Physiol. 281: 563-570.
52. Moon KS (1991). The components and utilization of medicinal plants. Ilweolseogak, Pyongyang , p.p. 419.
53. Namba T (1994). The encyclopedia of traditional sino-japanese medicine with color pictures. Vol 2. Hoikusha Co., Ltd, Osaka p. 154.
54. Neihoerster M, Inoue M, Wendel A (1992). A link between extracellular reactive oxygen and endotoxin-induced release of tumor necrosis factor alpha in vivo. Biochem. Pharmacol. 43: 1151-1154.
55. Ohtani K, Mizutani K, Kasai R, Tanaka O (1984). Selective cleavage of ester type glycoside-linkage and its application to structure determination of natural oligoglycosides. Tetrahadron Lett. 25: 4537-4540.
56. Park H, Kim MS, Jeon BH, Kim TK, Kim YM, Ahnn J, Kwon DY, Takaya Y, Wataya Y, Kim H-S (2003). Antimalarial activity of herbal extracts used in traditional medicine in Korea. Biol. Pharm. Bull. 26: 1623-1624.
57. Park HJ, Kim DH, Choi JW, Park JH, Han YN (1998). A potent antidiabetic agent from Kalopanax pictus. Arch. Pharm. Res. 21: 24-29.
58. Park HJ, Lee KT, Jung WT, Choi JW, Kadota S (1999). Protective effect of syringin isolated from Kalopanax pictus on galactosamine-induced hepatotoxicity. Nat. Med. 53: 113-117.
59. Park HJ, Nam JH, Jung HJ, Kim WB, Park KK, Chung WY, Choi J (2005). In vivo antinociceptive antiinflamatory and antioxidative effects of the leaf and stem bark of Kalopanax pictus in rats. Kor. J. Pharmacogn. 36: 318-323.
60. Park IB (2000). Beverage containing thorny ash extracts. KR Patent No. KR/10/2000/0070714.
61. Park MJ, Ha DR (1991). Saponins from the stem bark of Kalopanax pictum var. magnificum (I). Arch. Pharm. Res. 14: 7-11.
62. Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY (2009). Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKC-medicaed signaling in MCF-7 human breast cancer cells. Carcinogenesis doi:10.1093/carcin/bgp1111. Pharm. Bull. 25: 472-476.
63. Neihoerster M, Inoue M, Wendel A (1992). A link between extracellular reactive oxygen and endotoxin-induced release of tumor necrosis factor alpha in vivo. Biochem. Pharmacol. 43: 1151-1154.
64. Sano K, Sanada S, Ida Y, Shoji J (1991). Studies on the constituents of the bark of Kalopanax pictus Nakai. Chem. Pharm. Bull. 39: 865-870.
65. Shao C-J, Kasai R, Ohtani K, Tanaka O, Kohda H (1990). Saponins from leaves of Kalopanax pictus (Thunb.) Nakai, Harigiri: Structures of Kalopanax-Saponins JLa and JLb. Chem. Pharm. Bull. 38: 1087-1089.
66. Shao CJ, Kasai R, Xu JD, Tanaka O (1989). Saponins from roots of Kalopanax septemlobus (Thunb.) Koidz., Ciqiu: structures of Kalopanaxsaponins C, D, E and F. Chem. Pharm. Bull. 37: 311-314.
67. Sharma SK, Ali M, Gupta J (2002). Hepatoprotective activity of aqueous ethanolic extract of Chamomile capitula in paracetamol intoxicated albino rats. Phytochem. Pharmacol. 2: 253-270.
68. Towler MC, Hardie DG (2007). AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Rec. 100: 328-341.
69. Vane JR, Botting RM (2003). The mechanism of action of aspirin. Thromb. Res. 110: 255-258.
70. Yeh GY, Kaptchuk TJ, Eisenberg DM, Phillips RS (2003). Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diab. Care 26: 1277-1294.
71. Yin JY, Meng Q, Wang ES (2005). Septemloside III: A nonasaccharide saponin from the bark of Kalopanax septemlobus (Thunb.) Koidz. Chinese Chem. Lett. 16: 53-56.